Handel i polityka gospodarcza · 24/06/2026
U.S. Launches Investigation into Germany's Underpayment for Innovative Pharmaceuticals
The U.S. Trade Representative has initiated a Section 301 investigation into Germany's persistent underpayment for innovative pharmaceutical products, holding a public hearing and seeking public comments.